• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相位分析门控心肌灌注 SPECT 评估左心室最佳导线位置。

Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT.

机构信息

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):230-8. doi: 10.1007/s00259-010-1621-z. Epub 2010 Oct 17.

DOI:10.1007/s00259-010-1621-z
PMID:20953608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3021712/
Abstract

PURPOSE

The aim of the current study was to evaluate the relationship between the site of latest mechanical activation as assessed with gated myocardial perfusion SPECT (GMPS), left ventricular (LV) lead position and response to cardiac resynchronization therapy (CRT).

METHODS

The patient population consisted of consecutive patients with advanced heart failure in whom CRT was currently indicated. Before implantation, 2-D echocardiography and GMPS were performed. The echocardiography was performed to assess LV end-systolic volume (LVESV), LV end-diastolic volume (LVEDV) and LV ejection fraction (LVEF). The site of latest mechanical activation was assessed by phase analysis of GMPS studies and related to LV lead position on fluoroscopy. Echocardiography was repeated after 6 months of CRT. CRT response was defined as a decrease of ≥15% in LVESV.

RESULTS

Enrolled in the study were 90 patients (72% men, 67±10 years) with advanced heart failure. In 52 patients (58%), the LV lead was positioned at the site of latest mechanical activation (concordant), and in 38 patients (42%) the LV lead was positioned outside the site of latest mechanical activation (discordant). CRT response was significantly more often documented in patients with a concordant LV lead position than in patients with a discordant LV lead position (79% vs. 26%, p<0.01). After 6 months, patients with a concordant LV lead position showed significant improvement in LVEF, LVESV and LVEDV (p<0.05), whereas patients with a discordant LV lead position showed no significant improvement in these variables.

CONCLUSION

Patients with a concordant LV lead position showed significant improvement in LV volumes and LV systolic function, whereas patients with a discordant LV lead position showed no significant improvements.

摘要

目的

本研究旨在评估门控心肌灌注 SPECT(GMPS)测定的机械激活最晚部位、左心室(LV)导线位置与心脏再同步治疗(CRT)反应之间的关系。

方法

入选患者为目前拟行 CRT 的晚期心力衰竭患者。植入前进行 2 维超声心动图和 GMPS 检查。超声心动图用于评估 LV 收缩末期容积(LVESV)、LV 舒张末期容积(LVEDV)和 LV 射血分数(LVEF)。通过 GMPS 相位分析评估机械激活最晚部位,并与透视下 LV 导线位置相关联。CRT 后 6 个月重复行超声心动图检查。CRT 反应定义为 LVESV 降低≥15%。

结果

共入选 90 例(72%为男性,平均年龄 67±10 岁)晚期心力衰竭患者。52 例(58%)患者 LV 导线位于机械激活最晚部位(一致),38 例(42%)患者 LV 导线位于机械激活最晚部位以外(不一致)。LV 导线位置一致的患者 CRT 反应明显更常见(79%比 26%,p<0.01)。6 个月后,LV 导线位置一致的患者 LVEF、LVESV 和 LVEDV 明显改善(p<0.05),而 LV 导线位置不一致的患者这些变量无明显改善。

结论

LV 导线位置一致的患者 LV 容积和 LV 收缩功能明显改善,而 LV 导线位置不一致的患者无明显改善。

相似文献

1
Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT.相位分析门控心肌灌注 SPECT 评估左心室最佳导线位置。
Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):230-8. doi: 10.1007/s00259-010-1621-z. Epub 2010 Oct 17.
2
Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy.基于心电图门控心肌灌注 SPECT 的左心室失同步定量评估新算法:心脏再同步治疗管理的有用技术。
Ann Nucl Med. 2011 Dec;25(10):768-76. doi: 10.1007/s12149-011-0525-8. Epub 2011 Aug 13.
3
LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure.通过门控心肌灌注单光子发射计算机断层扫描的相位分析评估左心室不同步可预测终末期心力衰竭患者对心脏再同步治疗的反应。
Res Cardiovasc Med. 2014 Nov 25;3(4):e20720. doi: 10.5812/cardiovascmed.20720. eCollection 2014 Nov.
4
A novel method combining gated SPECT and vectorcardiography to guide left ventricular lead placement to improve response to cardiac resynchronization therapy: A proof of concept study.一种结合门控 SPECT 和心向量图的新方法,用于指导左心室导线放置以改善心脏再同步治疗反应:概念验证研究。
J Nucl Cardiol. 2024 Jun;36:101867. doi: 10.1016/j.nuclcard.2024.101867. Epub 2024 Apr 30.
5
Value of intraventricular dyssynchrony assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients undergoing cardiac resynchronization therapy (VISION-CRT).门控 SPECT 心肌灌注显像评估心室不同步在心力衰竭患者心脏再同步治疗管理中的价值(VISION-CRT)。
J Nucl Cardiol. 2021 Feb;28(1):55-64. doi: 10.1007/s12350-018-01589-5. Epub 2019 Jan 25.
6
Relationship of Electromechanical Dyssynchrony in Patients Submitted to CRT With LV Lead Implantation Guided by Gated Myocardial Perfusion Spect.门控心肌灌注显像引导下左心室电极植入的心脏再同步治疗患者的机电不同步关系
Arq Bras Cardiol. 2018 Oct;111(4):607-615. doi: 10.5935/abc.20180159. Epub 2018 Aug 23.
7
Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT.存活心肌的左心室失同步通过心肌灌注 SPECT 预测 CRT 的机械反应。
Ann Nucl Med. 2021 Aug;35(8):947-954. doi: 10.1007/s12149-021-01632-5. Epub 2021 May 21.
8
Cardiac resynchronization therapy outcomes with left ventricular lead concordant with latest mechanical activation: A meta-analysis.左心室导线与最新机械激活一致的心脏再同步治疗结果:一项荟萃分析。
Pacing Clin Electrophysiol. 2022 Aug;45(8):930-939. doi: 10.1111/pace.14549. Epub 2022 Jun 21.
9
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).心脏再同步治疗中最佳左心室导线位置的预后获益:TARGET 研究队列的随访结果(靶向左心室导线位置指导心脏再同步治疗)。
JACC Heart Fail. 2014 Jun;2(3):205-12. doi: 10.1016/j.jchf.2013.11.010.
10
Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.电间期延长与假定左心室起搏部位优化患者对心脏再同步治疗的反应相关。
Europace. 2018 Oct 1;20(10):1630-1637. doi: 10.1093/europace/eux384.

引用本文的文献

1
Additive Value of Cardiac Dyssynchrony Parameters using Rest Myocardial Perfusion SPECT in the Diagnosis of Cardiac Sarcoidosis: A Cross-sectional Analytical Study.静息心肌灌注单光子发射计算机断层扫描评估心脏不同步参数在心脏结节病诊断中的附加价值:一项横断面分析研究
Indian J Nucl Med. 2025 Mar-Apr;40(2):72-78. doi: 10.4103/ijnm.ijnm_86_24. Epub 2025 Jun 27.
2
A New Method Using Deep Learning to Predict the Response to Cardiac Resynchronization Therapy.一种使用深度学习预测心脏再同步治疗反应的新方法。
J Imaging Inform Med. 2025 Feb 20. doi: 10.1007/s10278-024-01380-8.
3
A new method of modeling the multi-stage decision-making process of CRT using machine learning with uncertainty quantification.

本文引用的文献

1
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.2009年重点更新内容纳入《美国心脏病学会/美国心脏协会2005年成人心力衰竭诊断与管理指南》:美国心脏病学基金会/美国心脏协会实践指南工作组报告:与国际心肺移植学会合作制定。
Circulation. 2009 Apr 14;119(14):e391-479. doi: 10.1161/CIRCULATIONAHA.109.192065. Epub 2009 Mar 26.
2
Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.最佳左心室电极位置可预测心脏再同步治疗后的逆向重构和生存率。
J Am Coll Cardiol. 2008 Oct 21;52(17):1402-9. doi: 10.1016/j.jacc.2008.06.046.
3
一种使用带有不确定性量化的机器学习对心脏再同步治疗(CRT)的多阶段决策过程进行建模的新方法。
ArXiv. 2024 Apr 28:arXiv:2309.08415v4.
4
Prediction of Cardiac Resynchronization Therapy Response Using Quantitative Gated Myocardial Perfusion Imaging.使用定量门控心肌灌注成像预测心脏再同步治疗反应
J Innov Card Rhythm Manag. 2023 Jan 15;14(1):5313-5321. doi: 10.19102/icrm.2023.14014. eCollection 2023 Jan.
5
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support.一种结合心电图和门控 SPECT 的机器学习方法,用于心脏再同步治疗决策支持。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3022-3033. doi: 10.1007/s00259-023-06259-4. Epub 2023 May 17.
6
Nuclear Cardiology in the Optimization of Resynchronization Therapy: Quo Vadis?核心脏病学在心脏再同步治疗优化中的作用:何去何从?
Arq Bras Cardiol. 2023 Apr 7;120(3):e20230136. doi: 10.36660/abc.20230136.
7
Estimation of left ventricular activation sequence in patients with heart failure using two-dimensional speckle tracking echocardiography.采用二维斑点追踪超声心动图评估心力衰竭患者左心室激活顺序。
Int J Cardiovasc Imaging. 2023 Jul;39(7):1251-1262. doi: 10.1007/s10554-023-02834-w. Epub 2023 Mar 27.
8
Prediction of Cardiac Resynchronization Therapy Response Using a Lead Placement Score Derived From 4-Dimensional Computed Tomography.基于 4D-CT 构建的导线位置评分预测心脏再同步治疗反应
Circ Cardiovasc Imaging. 2022 Aug;15(8):e014165. doi: 10.1161/CIRCIMAGING.122.014165. Epub 2022 Aug 16.
9
A Mild Dyssynchronous Contraction Pattern Detected by SPECT Myocardial Perfusion Imaging Predicts Super-Response to Cardiac Resynchronization Therapy.单光子发射计算机断层扫描心肌灌注成像检测到的轻度不同步收缩模式可预测心脏再同步治疗的超反应。
Front Cardiovasc Med. 2022 May 31;9:906467. doi: 10.3389/fcvm.2022.906467. eCollection 2022.
10
Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with different pathophysiology.左心室机械不同步对不同病理生理心力衰竭患者 CRT 反应的预测价值。
J Nucl Cardiol. 2022 Oct;29(5):2637-2648. doi: 10.1007/s12350-021-02796-3. Epub 2021 Sep 17.
2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2008年聚焦更新纳入美国心脏病学会/美国心脏协会2006年瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组(修订1998年瓣膜性心脏病患者管理指南写作委员会)报告:得到心血管麻醉医师协会、心血管造影和介入学会以及胸外科医师协会认可。
Circulation. 2008 Oct 7;118(15):e523-661. doi: 10.1161/CIRCULATIONAHA.108.190748. Epub 2008 Sep 26.
4
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.《美国心脏病学会/美国心脏协会/心律学会2008年心脏节律异常器械治疗指南》:美国心脏病学会/美国心脏协会实践指南工作组(修订ACC/AHA/NASPE 2002年心脏起搏器和抗心律失常器械植入指南更新的写作委员会)报告:与美国胸外科协会和胸外科医师学会合作制定。
Circulation. 2008 May 27;117(21):e350-408. doi: 10.1161/CIRCUALTIONAHA.108.189742. Epub 2008 May 15.
5
Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging.通过心电图门控单光子发射计算机断层扫描心肌灌注成像的相位分析评估左心室机械性不同步。
J Nucl Cardiol. 2008 Jan-Feb;15(1):127-36. doi: 10.1016/j.nuclcard.2007.11.004.
6
Effects of myocardial wall thickness on SPECT quantification.心肌壁厚度对 SPECT 定量的影响。
IEEE Trans Med Imaging. 1990;9(2):144-50. doi: 10.1109/42.56338.
7
Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.心脏再同步治疗中左心室导线位置对左心室重构的影响。基于二维超声心动图的圆周应变分析。
Eur Heart J. 2007 May;28(10):1211-20. doi: 10.1093/eurheartj/ehm034. Epub 2007 Apr 10.
8
The interaction of interventricular pacing intervals and left ventricular lead position during temporary biventricular pacing evaluated by tissue Doppler imaging.通过组织多普勒成像评估临时双心室起搏期间心室间起搏间期与左心室导联位置的相互作用。
Heart. 2007 Nov;93(11):1426-32. doi: 10.1136/hrt.2006.087445. Epub 2007 Feb 3.
9
Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients.存活能力和瘢痕组织对缺血性心力衰竭患者心脏再同步治疗反应的影响。
Eur Heart J. 2007 Jan;28(1):33-41. doi: 10.1093/eurheartj/ehl379. Epub 2006 Nov 22.
10
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients.预测缺血性心力衰竭患者心脏再同步治疗反应的存活范围
J Nucl Med. 2006 Oct;47(10):1565-70.